Abstract Aging is associated with an increased risk of depression in humans. To elucidate the underlying mechanisms of depression and its dependence on aging, here we study signs of depression in male SAMP8 mice. For this purpose, we used the forced swimming test (FST). The total floating time in the FST was greater in SAMP8 than in SAMR1 mice at 9 months of age; however, this difference was not observed in 12-month-old mice, when both strains are considered elderly. Of the two strains, only the SAMP8 animals responded to imipramine treatment. We also applied the dexamethasone suppression test (DST) and studied changes in the dopamine and serotonin (5-HT) uptake systems, the 5-HT 2a/2c receptor density in the cortex, and levels of TPH2. The DST showed a significant difference between SAMR1 and SAMP8 mice at old age. SAMP8 exhibits an increase in 5-HT transporter density, with slight changes in 5-HT 2a/2c receptor density. In conclusion, SAMP8 mice presented depression-like behavior that is dependent on senescence process, because it differs from SAMR1, senescence resistant strain.
Introduction
Aging is associated with increased depression in humans. Although this condition is one of the most prevalent psychopathologies worldwide (Murray and Lopez 1997) , it is often not recognized or treated. The pathophysiology of depression has been associated with dysfunction in dopamine (DA) and serotonin (5-HT) neurotransmission (Nutt 2006) . Age also brings changes in 5-HT and DA levels in humans in certain neurodegenerative diseases (Gareri et al. 2002; Potter et al. 2012 ; Gourley and Taylor 2009; Ownby et al. 2006) . Moreover, the levels of D2 and D1 receptors in suicidal individuals remain unchanged, while the turnover of DA is modified. Although the serotonergic system has many components, the serotonin transporter (SERT), the serotonin 1a receptor (5-HT 1a ), and the serotonin 2a receptor (5-HT 2a ) are those most closely associated with the neurobiology of mood.
The most highly prescribed medications for depression are 5-HT selective reuptake inhibitors that alter SERT protein levels and also its mRNA levels (Smith 1991 ; Owens and Nemeroff 1998) . Depressed patients show a reduction in 5-HT metabolites in the serotonergic system. The involvement of 5-HT 1a receptors in human depression has been demonstrated, as their concentrations are markedly lower in depressed people than in people who are not depressed. Many electrophysiological studies have shown that antidepressants upregulate or ''sensitize'' 5-HT 1a function in the hippocampus, while at the same time downregulating or ''desensitizing'' 5-HT 1a function in the raphe, where this neurotransmitter acts as an inhibitory somatodendritic receptor (Blier and de Montigny 1994) . The 5-HT 2a receptor has also been shown to be affected by chronic antidepressant treatment. Most, but not all, studies have reported decreases in 5-HT 2a binding in the prefrontal cortex after chronic antidepressant administration (Bourin and Baker 1996; Peroutka and Snyder 1980) . The opposite changes (5-HT 2a upregulation) have been reported in the prefrontal cortex of suicide victims (Mann et al. 1986; Arango et al. 1990 ), although these findings are not universal (Stockmeier 1997) . In addition, subjects with a history of depression who die of natural causes have been shown to present increases in 5-HT 2a binding in the prefrontal cortex (Yates et al. 1990 ). There is accumulating genetic and neurobiological evidence of the critical role of tryptophan hydroxylase-2 (TPH2), the key enzyme for synthesis of 5-HT, in central serotonergic system function and in the pathophysiology of a wide spectrum of disorders affecting cognitive control and emotion regulation, ranging from depression to attention-deficit/hyperactivity disorder (Waider et al. 2011) . Several studies drawn also the implication of BDNF in depression and has received considerable support the functional Val66Met polymorphism of the gene encoding BDNF, which may reduce BDNF expression particularly when exposed to stress and thus may play a critical role in the pathogenesis of depression (Groves 2007; Kimpton 2012 ).
The senescence accelerated mouse (SAM), a murine model of aging, is generated from autogenic senile strains of mice (Takeda et al. 1981 (Takeda et al. , 1991 . There are nine senescence-prone strains (SAMP) and three senescence-resistant one (SAMR). SAMR strains are resistant to early senescence and are used as controls. Among the SAMP strains, SAMP8 and SAMP10 exhibit deficits in learning and memory at relatively early stages of life. SAMP8 mice also produce increased amounts of amyloid precursor protein (APP) and amyloid-b similar to those observed in Alzheimer's disease (AD) patients (Butterfield and Poon 2005) and spontaneous overproduction of soluble Ab in the hippocampus and cortex (Petursdottir et al. 2007; Gutierrez-Cuesta et al. 2008) . Therefore this strain may be a suitable model with which to study the fundamental mechanisms of age-related alterations in the central nervous system (CNS) and to evaluate the effects of drugs.
There is little evidence that the SAM strains show the symptoms of depression. Furthermore, studies suggest that SAMP8 mice exhibit an age-related emotional disorder characterized by reduced anxietylike behavior (Miyamoto et al. 1992) . Tests of learning strategies have demonstrated differences in 5-HT 1 and 5-HT 2 receptor activity in 12-and 4-month-old SAMP8 animals (Flood et al. 1998 ).
Here we studied signs of depression in male SAMP8 mice in order to elucidate the underlying mechanisms of depression and its dependence on aging. Firstly, male SAMP8 and SAMR1 mice were subjected to the forced swimming test (FST). We also tested reversion due to imipramine treatment in both strains. Finally, as markers of the neurobiological and anatomical basis of depression, the dexamethasone suppression test (DST) and changes in the DA and 5-HT uptake systems, 5-HT 2a/2c receptor density in the cortex and TPH2 protein levels were studied in male SAMP8 and SAMR1.
Methods

Animals
The experimental protocols for the use of animals in this study were approved by the Animal Ethics Committee of the University of Barcelona under the supervision of the Autonomous Government of Catalonia, following the guidelines of the European Communities Council (86/609/EEC). Efforts were made to minimize suffering and reduce the number of animals used. Male 6-, 9-and 12-month-old SAMR1 and SAMP8 mice were used in all experiments, which were housed at 22 ± 1°C under a 12-h light/dark cycle with free access to food and drinking water. Mean lifespan for SAMR1 are 16.3 months and for SAMP8 are 9.7 months).
Forced swimming test
To conduct the FST, animals (9-14 different mice for each experimental group) were placed in a plexiglass cylinder (10 cm internal diameter, 50 cm high) filled with water (10 cm height) at 22-25°C. Duration of the experiment was 5 min; the behavior of the animals was evaluated during 3 min between the 2nd and 5th min and immobility time was measured. A mouse was judged to be immobile when it remained floating in the water, making only those movements necessary to keep its head above the water (Porsolt 2000; Porsolt et al. 1977) . The experiment was carried out before and after the imipramine treatment regime (30 mg/kg IP, once a day for 7 days).
CompuLet 5 system (Panlab SL, Barcelona, Spain) was used to quantify the changing state of mobility to immobility (named as event) and also the time spent in each event (s/event). For each experimental group events were expressed as the median ± semi-interquartile range, and statistically significant changes were analyzed with a Kruskal-Wallis test for nonparametric data, followed by U Mann-Whitney test. The difference between groups in the immobility time for each event was calculated using two-way ANOVA.
Dexamethasone suppression test
The DST was performed in male , n = 9-10 for each experimental group). A blood sample was collected between 18:00 and 20:00 h from separate cohorts of mice at baseline or after injection of one dose of dexamethasone (6 lg/kg i.p. diluted in saline). Blood samples were collected through the facial vein 8-9 h after injection in microtubes containing K 3 -EDTA. The samples were centrifuged at 1,0009g for 10 min at 4°C; plasma were collected and stored at -80°C until corticosterone concentrations were assessed with a radioimmunoassay ( 125 I RIA Kit Immunchem Double Antibody Corticosterone, MP Biomedical LLC).The radioimmune assay was conducted following the manufacturer instructions. This assay is highly specific, cross reacting at less than 0.35 % with other hormones and a detection limit of 7.7 ng/ml. The standard curve was run in triplicate and samples were run in duplicate. All samples within an experiment were run in the same assay. Results were expressed as the difference in the corticosterone levels before and after administration of the drug. Statistically significant changes were analyzed using a two-way ANOVA followed by Tukey post hoc tests.
Determination of transporters and receptors
Tissue sample preparation SAM-P8 and SAM-R1 mice 6-, 9-and 12-month-old (n = 6 different mice for each experimental group) were killed by cervical dislocation. Immediately after sacrifice, they were decapitated and the brains rapidly removed from the skull. Striata, parietal cortex, frontal cortex and hippocampus were quickly dissected out, frozen on dry ice and stored at -80°C until use. When required, tissue samples were thawed and homogenized at 4°C in 10 volumes of buffer consisting of 5 mM Tris-HCl, 320 mM sucrose and protease inhibitors (aprotinin 4.5 lg/ll, 0.1 mM phenylmethylsulfonyl fluoride and 1 mM sodium orthovanadate), pH 7.4, with a polytron homogenizer. The homogenates were centrifuged at 1,0009g for 15 min at 4°C. Aliquots of the resulting supernatants were taken, and after the protein concentration was determined, they were frozen and kept for Western blot experiments. The pellets were resuspended with the remaining supernatants and centrifuged at 15,0009g for 30 min at 4°C. The pellets were resuspended in fresh buffer and incubated at 37°C for 10 min in order to remove endogenous neurotransmitters. The protein samples were then re-centrifuged and washed two more times. The final pellets (crude membrane preparation) were resuspended in the appropriate buffer and stored at -80°C for use in radioligand binding experiments. Protein content was determined using the Bio-Rad Protein Reagent (Bio-Rad Labs. Inc., Hercules, CA, USA),according to the manufacturer's specifications. Biogerontology (2013) 14:165-176 167
Western blotting and immunodetection
For immunodetection procedures, 20 lg of protein was separated by SDS-PAGE (5-15 %) and transferred to PVDF membranes (Millipore). The membranes were blocked in 5 % non-fat milk in TBS containing 0.1 % Tween 20 (TBS-T) for 1 h at room temperature, followed by overnight incubation at 4°C with primary TPH2 (1:1,000, M-59, SantaCruz) and bactin (1:20,000; Sigma) antibodies diluted in TBS-T containing 5 % BSA. Membranes were then washed and incubated with peroxidase-conjugated secondary antibodies for 1 h at room temperature. Protein bands were view by a chemiluminescence detection kit (Amersham Biosciences). Band intensities were quantified by densitometric analysis using a BioRad ChemiDoc XRS gel documentation system (BioRad Labs., Hercules, CA, USA), and values were normalized to ß-actin expression.
Radioligand binding experiments
The density of serotonin transporters (SERT) in hippocampal membranes was quantified by measuring the specific binding of 0.1 nM [ 3 H]Paroxetine after incubation with 150 lg protein at 25°C for 2 h in a Tris-HCl buffer (50 mM, pH 7.4), containing 120 mM NaCl and 5 mM KCl to a final volume of 1.6 ml. Clomipramine (100 lM) was used to determine non-specific binding.
The density of dopamine transporter (DAT) in striatal membranes was measured by [ 3 H]WIN 35428 equilibrium binding assays as described elsewhere (Chipana et al. 2006) . Membranes were resuspended in phosphate-buffered 0.32 M sucrose, pH 7.9 at 4°C to a concentration of 1 lg/ll. Binding assays were performed in borosilicate glass tubes containing 200 ll of [ 3 H]WIN 35428 dilution in phosphatebuffered 0.32 M sucrose (final radioligand concentration: 5 nM) and 50 ll of membranes. Incubation was done for 2 h at 4°C. Non-specific binding was determined in the presence of 30 lM bupropion.
The density of 5-HT 2A receptors was measured in membranes of frontal cortex by determining the specific binding of [ 3 H]Ketanserine. These experiments were performed in tubes containing 1 nM [ 3 H]Ketanserin and 100 lg of brain membranes. Incubation was carried out at 37°C for 30 min in 50 mM Tris-HCl buffer to a final volume of 0.5 ml.
Methysergide (10 lM) was used to determine nonspecific binding.
All incubations were finished by rapid filtration under vacuum through GF/B glass fibre filters (Whatman, Maidstone, UK). Tubes and filters were washed rapidly 3 times with 4 ml ice-cold buffer and the radioactivity in the filters was measured using a liquid scintillation counter. Specific binding was calculated as the difference between the radioactivities measured in the absence (total binding) and presence (nonspecific binding) of an excess of non-labeled ligand. All assays were carried out in duplicate tubes and the mean specific binding for each mouse was calculated.
Statistical analysis
All data are expressed as mean ± standard error of the mean (SEM). Differences between groups were compared using the appropriate statistical test: KruskalWallis for non-parametric data, followed by U MannWhitney and for parametric data two-way ANOVA followed by Tukey post hoc tests. For qualitative data Chi square was applied. All calculations were performed using InVivoStat software (British Association of Psychopharmacology).
Drugs and reagents
Drugs and reagents were obtained from the following sources: aprotinin, bupropion, clomipramine, dexamethasone, imipramine, methysergide, phenylmethylsulfonyl fluoride, sodium orthovanadate were from Sigma-Aldrich (St. Louis, MO, USA 
Results
Forced swimming test (FST)
We compared the behavior of SAMR1 (6-to 12-month-old) animals with that of SAMP8 (6-to 12-month-old) animals in the FST. The mice were initially active when placed in the cylinder. After 1-2 min their activity began to decrease and the duration of immobility was measured. Immobility in the last 3 min of the test is considered an index of despair in response to stress and this behavioral despair is sensitive to antidepressant treatments (Porsolt et al. 1978) .
The immobility behavior of the two strains differed. Differences were determined for number of immobility events (KW 46, 919, d .f. 5, P \ 0.0001; post hoc test SAMR1 vs SAMP8 age-matched: U 6 months = 183, P \ 0.001; U 9 months = 188, P \ 0.001; U 12 months = 853, P \ 0.01, Fig. 1 ) and also for time of immobility in each event (two-way ANOVA, variable strain [F(1,73) = 27.9, P \ 0.001], variable age [F(2,73) = 5.4, P \ 0.01]; Tukey's post hoc test SAMR1 versus SAMP8 age-matched: 6 months P \ 0.05, 9 months P \ 0.001, 12 months P \ 0.01). SAMR1 animals were observed to constantly change from a mobile to an immobile state so that periods of immobility were short. In contrast, SAMP8 animals remained immobile for longer and consequently the number of times they changed from an active to an inactive state was lower (Fig. 1) . This differential behavior in the FST may indicate that SAMR1 mice make a greater effort to escape from the cylinder than SAMP8 counterparts.
We analyzed the effects of aging on immobility behavior of both strains. Post-hoc analysis revealed that at an age of 9 months SAMP8 animals spent longer immobility that SAMR1, but returned to a value that did not differ from that of SAMR1 at 12 months, at which it is assumed that both strains are aged (see Fig. 1 ) (variable strain [F(1,73) = 5.24, P \ 0.05]; variable age 9 strain [F(2,73) = 4.33,
Behavior in the FST is reversed by chronic or subacute antidepressant treatment and thus this test is used as an index of depression-like symptomatology (Porsolt et al. 1977 (Porsolt et al. , 1978 . When reversion in depressive behavior was tested using imipramine, we observed that repeated administration of this drug caused a decrease in the total floating period, especially in SAMP8 mice. We measured imipramine reversion by calculating immobility time differences before treatment by imipramine and after 3 or 7 days post-administration. Results indicate that only SAMP8 9 and 12 months aged were responsive to imipramine (two-way ANOVA, variable strain: 6 months [F(1,30) = 1.82, n.s.], 9 months [F(1,30) = 4.22, P \ 0.05], 12 months [F(1,72) = 4.99, P \ 0.05] (Fig. 2a-c) ).
Moreover, in order valuate this response, we considered a positive response to imipramine (responsive mice) to be when the reduction in immobility time was equal to or greater than 25 %, according previous reports (Blazer 1989; Kumar et al. 2006) . Therefore, when response to imipramine was tested by means of the FST after 3 and 7 days of treatment, SAMP8 animals responded to the antidepressant drug, whereas SAMR1 mice were less sensitive to treatment (Fig. 2d-f) . Dexamethasone suppression test
As a measure of the physiological response of the hypothalamic-pituitary-adrenal axis (HPA), we studied the feedback control of cortisol levels after dexamethasone administration. While cortisol levels in 6-and 9-month-old SAMR1 mice decreased after dexamethasone injection, age-matched SAMP8 animals showed no modification in cortisol plasma levels in response to corticoid administration. Post-hoc analysis showed that this difference in HPA functionality was not present in 12-month-old animals of either strain (two-way ANOVA, variable strain [F(1,59) = 7.51, P \ 0.01], Fig. 3 ). . Right column: percentage of responsive mice after 3 or 7 days of imipramine treatment in animals aged 6 months (d), 9 months (e) and 12 months (f). We considered a positive response to imipramine (responsive mice) to be when the reduction in immobility time was equal to or greater than 25 %. Exact Fisher test: *P \ 0.05, ***P \ 0.001 SAMP8 versus age-matched SAMR1
Radioligand binding experiments
Serotonin transporter (SERT)
To determine SERT density [ 3 H]Paroxetine binding was measured in the hippocampus and parietal cortex of mice killed at ages of 6, 9 and 12 months.
In hippocampus two-way ANOVA revealed a significant interaction age x strain [F(2,28) = 3.37, P \ 0.05]. Post-hoc analysis evidenced that SAMP8 mice hippocampus showed a significantly greater density of [ 3 H]Paroxetine binding sites at 9 and 12 months than age-matched SAMR1 counterparts. These differences were approximately 34 % at 9 months and 55 % at 12 months compared to SAMR1 mice (see Fig. 4a) .
Results in the parietal cortex (Fig. 4b) showed that aged animals exhibited a decrease in the SERT density (two-way ANOVA, variable age [F(2,32) = 15.87, P \ 0.001]). Moreover, SAMP8 mice exhibited higher [
3 H]Paroxetine binding density than SAMR1 counterparts (two-way ANOVA, variable strain [F(1,32) = 47.07, P \ 0.001]).
Dopamine transporter
To quantify the density of DAT, [ 3 H]WIN 35428 binding was measured in the striatum of mice killed at 6-, 9-and 12-months of age. ANOVA revealed no statistically significant differences between SAMR1 and SAMP8 animals (see Fig. 5 ). Only 12-month-old SAMR1 mice showed a slight decrease in DA reuptake sites compared with younger animals of the same strain.
5-HT 2A/2C receptors
The density of serotonergic 5-HT 2A/2C receptors in the frontal cortex was determined in cortical membranes by measuring the specific binding of [ 3 H]Ketanserine. Although the increase in older animals did not reach statistical significance, the 5-HT 2A/2C receptor density tended to increase with age in 12-month-old SAMR1 animals while SAMP8 mice showed constant levels of (Fig. 6) ). Fig. 3 Feedback control of corticosterone levels before and after dexamethasone administration in 6-, 9-and 12-month-old SAMR1 and SAMP8 mice. Bars represent mean ± SEM from 9 to 10 animals; experiments were carried out in duplicate. Twoway ANOVA and Tukey's post hoc test: **P \ 0.01 and ***P \ 0.001 SAMP8 versus age-matched SAMR1 U P \ 0.05 and UU P \ 0.01 SAMP8 versus age-matched SAMR1
Tryptophan hydroxylase content
Levels of TPH2 were determined by Western blot in the frontal cortex of 6-, 9-and 12-month-old SAMR1 and SAMP8 mice. No significant differences were found in the rate limiting enzyme for 5-HT synthesis (Fig. 7) .
Discussion
In humans, the incidence of depression and impairment of cognitive function, most notably spatial memory, is higher among the elderly; the prevalence of major depression is estimated to be between 1 and 10 % of individuals over 60 years of age or older, whereas depressive symptoms may occur in up to 20 % (Blazer 1989; Smith 1991; Kumar et al. 2006) . 5-HT neurotransmission is modified during aging, which suggests that aging is associated with decreased serotonergic neurotransmission in the CNS Klein et al. 2010) . Some of the alterations that reinforce this relationship are the increase in 5-HT terminal autoreceptors, 5-HT 1B receptors, and SERT binding sites with age (Duncan et al. 2000) . Given the importance of threat detection to survival, the neural mechanisms underlying the behavioral and physiological manifestations of anxiety are highly conserved, and thus enable the use of animal models to investigate relationships between stressors and psychopathological function (O' Neil and Moore 2003) .
Senescence accelerated mouse (SAM), a murine model of accelerated senescence, was established by Takeda et al. (1981 Takeda et al. ( , 1991 . Among the SAMP strains, SAMP8 mice show significant impairments in a variety of learning tasks when compared with SAMR1 animals (Ownby et al. 2006; Takeda 2009 ). Further studies suggest that the SAMP8 model exhibits an agerelated emotional disorder characterized by reduced anxiety-like behavior (Karasawa et al. 1999 ). It had been demonstrated an age-dependent diminution in BDNF expression in SAMP8 versus SAMR1 (Alvarez-López et al. 2013) and BDNF hypothesis of depression postulates that a reduction in BDNF is directly involved in the pathophysiology of depression, reinforcing the robustness of SAMP8 as a depression-like behavior associated to age (Groves 2007; Kimpton 2012; Lotrich 2012) .
Among the SAMP strains, SAMP10 exhibits agerelated brain atrophy and learning impairments in avoidance tasks (Shimada et al. 1992 (Shimada et al. , 1993 . Interestingly, at 7-8 months of age SAMP10 animals show depressive behavior in tail suspension and FST (Onodera et al. 2000; Shimada et al. 1992) , which are common behavioral tests for depression-related behavior in animals (Miyamoto 1997; Buddenberg et al. 2009 ). An increase in D 2 receptors in the cortex and midbrain, but not in the striatum or cerebellum, was detected in SAMP10 mice (Onodera et al. 2000) . The same authors observed that this strain showed an increase in cortex and midbrain 5-HT 1A receptors with respect to SAMR1, while the binding of ketanserin (5-HT 2 ) remained unchanged. There are also receptor levels in the frontal cortex of 6-, 9-and 12-month-old SAMR1 and SAMP8 mice. Bars represent mean ± SEM from six different samples carried out in triplicate. ANOVA revealed a non-significant effect of age on receptor binding but also a non-significant difference between SAMP8 and SAMR1 at all ages discrepancies with the changes seen in humans. Miyamoto et al. (1986) reported that SAMP10 mice showed behavioral depression compared with the control SAMR1 strain in a tail suspension test, although SAMP8 animals did not. Conversely, in the SAMP8 strain, lower DA replacement is observed in aged animals than in young ones (10 and 2 months) (Ida et al. 1985) . Okuma et al. (2000) demonstrated changes in neurotransmission by various types of receptors in SAMP8 animals. The noradrenergic system may be extensively involved in behavioral disorder-related fear, stress and anxiety (Karasawa et al. 1999) . Biochemical studies performed by Nomura and colleagues demonstrated that there was an age-associated reduction in K ? -or NMDA-evoked release of noradrenalin and an increase in a 2 receptors in the brain of SAMP8 animals (Kitamura et al. 1989; Zhao and Nomura 1990) . On the basis of these results, it has been suggested that the deterioration in the noradrenergic system contributes to reduced anxiety-like behavior. In contrast, Miyamoto (1997) , using the tail suspension test, reported no changes in depressionlike behavior in the SAMP8 strain, while SAMP10 mice exhibited significant depression compared with control SAMR1 counterparts.
Here we sought to establish SAMP8 as a behavioral model of age-related depression. For this purpose we first applied the FST. The mice showed depressionlike behavior at 9 months of age but not younger, compared with age-matched SAMR1. At 9 months, and given that the lifespan of the SAMP8 strain is 40 % shorter than that of SAMR1 mice (9.7 and 16.3 months, respectively) (Takeda et al. 1991) , the former were at the end of their lifecycle. Our results indicate that 9-month-old SAMP8 animals show a longer total time of immobility and a lower number of events during immobility than age-matched SAMR1 animals. However, at 12 months of age, there were no significant differences between the two strains. We found a significant increase in responsive SAMP8 mice after imipramine treatment, followed by a reversion of depressive behavior when increases in noradrenalin and 5-HT availability in synapses were induced. These observations provide clues as to the molecular mechanism that induces depressive behavior in these mice.
SAMP8 mice (at 9 and 12 months of age) presented a low availability of 5-HT in the synaptic cleft due to an increase in SERT, measured as [ 3 H]Paroxetine binding, when compared with age-matched SAMR1 mice. The most notable difference in SERT density shows quantification of tryptophane hydroxylase 2 (TPH2) levels from all the western blots performed. bactin expression was used as a gel load control and to normalize the results as the ratio TPH/b-actin expression. Western blots were performed with samples from at least four animals from each group in duplicate. ANOVA revealed a non-significant differences in expression levels of TPH/b-actin but also a nonsignificant difference between SAMP8 and SAMR1 at all ages between the two strains was seen at 9 months of age (25 % in hippocampus and 86 % in parietal cortex). These results correlate with the high responsiveness to imipramine, a 5-HT reuptake inhibitor, in the behavioral test. Measurements of tryptophan hydroxylase protein levels allowed us to rule out the notion of defective 5-HT synthesis.
The depressive behavior of the SAMP10 strain is related to alterations in brain DA and 5-HT receptors and this mouse has previously been proposed as a useful model of aging associated depressive behavior (Flood et al. 1998) . Conversely, we found no significant changes in 5-HT2a receptor densities in SAMR1 or SAMP8, or between ages; although SAMR1 animals showed an age-related up-regulation tendency that was not present in the SAMP8 strain. The involvement of the DA uptake in depression-like behavior observed in SAMP8 mice can be ignored because no changes in DA transporter were detected in SAMR1 or SAMP8 mice at the ages studied.
Depressive behavior is also controlled by the HPA axis. It has been determined that the HPA system is hyperactive in major depressive disorders. Chronic corticosterone treatment of rats and mice produces changes in emotional behavior that may correspond to symptoms of clinical depression and anxiety (for a review, see Gourley and Taylor 2009) . The DST has been used extensively to measure the deregulation of the HPA axis in humans (Carrol et al. 1981) .Concerning the chronic corticosterone model, Iijima et al. (2010) showed that the selective serotonin reuptake inhibitor (SSRI) fluvoxamine and the tricyclic antidepressant imipramine are not effective in decreasing the immobility time of chronic corticosterone-treated rats, here we used a single dexamethasone administration as described.
Results on the control of cortisol release by the HPA axis indicate that 6-, and 9-month-old SAMP8 mice were not able to suppress the daily increase in glucocorticoids following dexamethasone administration, and this fact can be considered as a marker of depression-like behavior. The control strain SAMR1 showed a loss in the feedback control of the HPA axis after dexamethasone treatment only at the oldest age tested (12 months), therefore again indicating a relationship between aging and the development of depressive disorders in SAM animals, these occurring both in the senescence accelerated model and in the control strain.
5-HT regulates the activation states of glycogen synthase kinase 3 (GSK3) through 5-HT1 (which inhibits GSK3) and 5-HT2 (which activates the kinase) receptors. Balanced GSK3 activity is essential for 5-HT-regulated brain function and behavior (Polter and Li 2011) . Depending on their age, SAMP8 mice are reported to have a higher level of activated GSK3b, which can be demonstrated by hyperphosphorylation of some of its substrates (Canudas et al. 2005; Casadesús et al. 2012) . Moreover, some drugs, such as antidepressants and atypical antipsychotics, regulate GSK3 by inhibiting its activity in the brain (for a review see Polter and Li 2011) .
Changes in GSK3b activity in SAMP8 mice reinforce the depression-like behavior reported in the present study, as described in other models (Chen et al. 2012 ).
Our findings demonstrate that 9-month-old SAMP8 mice show age-associated changes in emotional behavior, particularly increasing depression-like behavior. Aged SAMR1 mice (12 months old) also showed a similar depression-like behavior to that of young (6-to 9-month-old) SAMP8 mice and age matched SAMP8 mice.
Conclusions
Together, our results show that the alterations in depression-like behavior in SAMP8 mice are related to age. Because aging is associated with an increased risk of depression in humans, this mice model can be an useful experimental tool to study age-related mechanism involved in depression. We hypothesize that the age-related increased depression-like behavior in SAMP8 animals is related to dysfunctions in the HPA axis, and to an increase in 5-HT transporter, with slight or marginally significant changes in 5-HT 2a receptors. The reversion of this behavior by imipramine treatment, a non-specific inhibitor of noradrenalin and 5-HT transporters, in the FST indicates the strong relation between the depression-like behavior in SAMP8 animals and levels of monoamines. On the basis of our results, we find that the SAMP8 mouse presents an alteration in serotoninergic system, that is relevant because the reduced levels of BDNF in these animals, and lead to develop a depressive-like behavior. These specific changes have been to take in account when research on behavior/learning is performed in this strain as a model of senescence.
